Visual outcomes with a non-diffractive enhanced depth-of-focus IOL in patients with age-related macular degeneration.

Front Med (Lausanne) · 2025 · PMC12203608 · PMID 40584705

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These IOLs, using two or three focal points may reduce contrast sensitivity in healthy patients in some circumstances ( 8 ) and it has been argued that this reduction may be significant in eyes with pre-existing contrast sensitivity impairment, such as those with concurrent diseases ( 9 ).

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.